Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
Original-Research

NFON AG (von NuWays AG): BUY 11.11.2026, 09:00 Uhr von EQS Research Jetzt kommentieren: 0

Werte zum Artikel
Name Aktuell Diff. Börse
NFON 3,515 EUR +4,61 % Lang & Schwarz
Kostenlose Aktienchance per SMS Ausgewählte Trading-Einschätzungen aufs Handy.

Original-Research: NFON AG - from NuWays AG

11.11.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to NFON AG

Company Name: NFON AG
ISIN: DE000A0N4N52
 
Reason for the research: Update
Recommendation: BUY
Target price: EUR 5
Target price on sight of: 12 months
Last rating change:
Analyst: Philipp Sennewald

Q3 preview: Seat decline to continue, margin to recover

On 19 November, NFON will publish its Q3 report. We expect another decline on the top line, while profitability should continue its sequential recovery. In detail:

Top line still declining, but at a slower pace. Q3 sales should come in at € 21.1m (eNuW), down 3.4% yoy, marking a sequential improvement vs Q2's -5.2%. The seat base should have shrunk faster than sales (eNuW: -4% to 622k), reflecting the ongoing simplification of the product portfolio and still muted order intake in the legacy PBX business. Blended ARPU should hold above € 10 (eNuW: € 10.03), as price increases and premium solutions cushion the volume decline. In H1, botario’s recurring revenues grew 24% to € 1.0m, while project revenues nearly halved. We expect this shift towards recurring to have continued in Q3, supported by the further productisation of the AI suite, keeping the recurring ratio at a strong 94%.

Q3 adj. EBITDA is seen to come in at € 2.5m (eNuW), implying a 11.8% margin vs 10.3% in H1. Main drivers are first savings from the support restructuring as well as continued other opex discipline. Yet, those cannot fully offset the ongoing sales decline, reflected in the yoy comparison (Q3'25: € 3.0m, 13.6% margin).

With our implied 9M at € 63.6m sales and € 6.9m adj. EBITDA, the FY guidance (€ 84.5-86.0m sales & € 9.5-10.5m adj. EBITDA) is well in reach, although we regard the lower ends of both ranges as the likely outcome, in line with 9M trendsImplied Q4 performance to reach the mid-points would be € 21.7m sales (-6.1% yoy) and € 3.1m adj. EBITDA (14.4% margin or -2.8pp yoy).

Demand appears intact. X-reading the operating performance of Gamma, NFON's most direct listed peer in Germany via Plactel and Starface, shows organic top-line growth in of 5% in H1 with a stated demand acceleration across partner and direct channels. We read that as follows: While demand is intact, NFON's decline is largely self-inflicted, driven by the portfolio simplification and a weaker UK (H1: -12.3% yoy), where Gamma also reports pricing pressure. In our view, the base should hence stabilize once the portfolio clean-up fades, allowing AI-driven ARPU growth to reaccelerate top line growth. Here, NFON should benefit from first-mover effects as most German peers are only now launching AI voice agents (Placetel AI in 2026, sipgate’s sona and Pascom’s Pia in September), while NFON has been building its stack since the botario acquisition in 2024 and released its own Text-to-Speech service in April. The head start also shows in the numbers, with botarios's recurring run rate of € 2m sales comparing to Gamma's € 600k AI run rate. This makes AI progress the key metric to track, which is why we would welcome dedicated AI KPIs in the company's reporting going forward.

Reiterate BUY, unchanged € 5.00 PT based on DCF.

You can download the research here: nfon-ag-2026-11-11-previewreview-en-16f2c
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2432314  11.11.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer